62. a Mendelian Randomization Study of Proprotein Convertase Subtilisin Kexin 9 Inhibition and Stroke: Evidence for Benefits Beyond Low-density Lipoprotein Cholesterol Lowering
Year: 2023
Type: article
Study design: Observational Study
Source: European Neuropsychopharmacology
Institutions: National Institutes of Health, University of Oxford
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4387497166
